These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5974192)

  • 21. [Therapeutic use of ornithine-carbamyl-transferase in liver diseases].
    Maccá F; Gatta A; Caregaro L; Lauro S; Milani L; Zuin R; Menozzi L
    Minerva Dietol Gastroenterol; 1982; 28(1):71-8. PubMed ID: 7078779
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of ornithine-ketoglutarate on provoked hyperammonaemia in patients with cirrhosis of the liver (author's transl)].
    Blahíková L; Horký J; Pechar J; Vidlaková M; Zvolánková K; Vosmík J; Marecková O
    Cesk Gastroenterol Vyz; 1978 Jun; 32(4):262-7. PubMed ID: 688420
    [No Abstract]   [Full Text] [Related]  

  • 23. [The therapy of states of exhaustion with Ornithin-Aspartat].
    Simon KH
    Med Monatsschr; 1968 Jan; 22(1):30-1. PubMed ID: 5707445
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy of lamivudine therapy for decompensated liver cirrhosis due to hepatitis B virus with or without hepatocellular carcinoma.
    Hiraoka A; Michitaka K; Kumagi T; Kurose K; Uehara T; Hirooka M; Yamashita Y; Kubo Y; Miyaoka H; Iuchi H; Okada S; Ohmoto M; Yamamoto K; Horiike N; Onji M
    Oncol Rep; 2005 Jun; 13(6):1159-63. PubMed ID: 15870937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical study on the effects of coenzyme A in liver diseases].
    Kanematsu Y; Okawa S; Himoto A; Inoue Y; Onishi K
    Naika Hokan; 1968 Mar; 15(3):67-75. PubMed ID: 5691520
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therapy of acute and chronic hepatitis. A clinical study using Inzolen infusion AM].
    Köhler FR; Ebel J
    Med Welt; 1979 Jul; 30(27):1056-60. PubMed ID: 381833
    [No Abstract]   [Full Text] [Related]  

  • 27. [Study of the in vitro effect of hydrocortisone and D-penicillamine on the liver of patients with chronic hepatitis and liver cirrhosis].
    Gichev IuP; Bakulina LF
    Ter Arkh; 1980; 52(7):113-7. PubMed ID: 7404399
    [No Abstract]   [Full Text] [Related]  

  • 28. Additional benefit of lamivudine treatment as a preventive therapy for hepatic encephalopathy in patients with decompensated liver cirrhosis associated with hepatitis B.
    Hanada S; Kumashiro R; Kaji R; Harada M; Sata M
    Int J Mol Med; 2002 Nov; 10(5):647-8. PubMed ID: 12373309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study of the action of Citiolone on hepatocellular cytolysis in decompensating cirrhosis and in active chronic hepatitis].
    Rev Med Chir Mal Foie; 1971; 46(2):95-8. PubMed ID: 5089130
    [No Abstract]   [Full Text] [Related]  

  • 30. Lamivudine treatment of decompensated hepatitis B virus-related cirrhosis.
    Zhang FK
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):10-5. PubMed ID: 16481275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect of Cpd 861 on chronic hepatitis B related fibrosis and early cirrhosis: a randomized, double blind, placebo controlled clinical trial].
    Yin SS; Wang BE; Wang TL; Jia JD; Qian LX
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):467-70. PubMed ID: 15329205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [On the therapy of chronic inflammatory liver diseases without or with vitamin B 12-folic acid].
    Burgmann W
    Munch Med Wochenschr; 1966 Sep; 108(37):1805-8. PubMed ID: 6014771
    [No Abstract]   [Full Text] [Related]  

  • 33. Validated method for L-ornithine-L-aspartate analysis in human plasma by capillary electrophoresis.
    Kowalski P; Bieniecki M; Oledzka I; Lamparczyk H
    Biomed Chromatogr; 2006 Feb; 20(2):185-94. PubMed ID: 16078310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prednisolone therapy of patients with chronic hepatitis and cirrhosis of the liver].
    Vasil'eva LN
    Klin Med (Mosk); 1966 May; 44(5):42-8. PubMed ID: 5990929
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparative study of renal glucose thresholds in hepatitis, cirrhosis and normal subjects receiving cortisone].
    Büyükyazgan T; Bölükoğlu MA; Göksel V
    Turk Tip Cemiy Mecm; 1968; 34(3):156-60. PubMed ID: 5684927
    [No Abstract]   [Full Text] [Related]  

  • 36. Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation.
    Chan HL; Chui AK; Lau WY; Chan FK; Wong ML; Tse CH; Rao AR; Wong J; Sung JJ
    J Med Virol; 2002 Oct; 68(2):182-7. PubMed ID: 12210406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lamivudine-stavudine-induced liver failure in hepatitis B cirrhosis.
    Schiano TD; Lissoos TW; Ahmed A; Siano C; Zaitman D; Cohn G; Ehrenpreis ED
    Am J Gastroenterol; 1997 Sep; 92(9):1563-4. PubMed ID: 9317091
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of Nucleotide precursors on experimental and clinical chronic hepatic disorders (a preliminary report).
    Katsuki S; Okumura M; Akitake T; Toyoshima Y; Nishi K; Furukawa K
    Kyushu J Med Sci; 1964 Dec; 15(5):171-81. PubMed ID: 5827933
    [No Abstract]   [Full Text] [Related]  

  • 39. The treatment of chronic liver diseases by means of an extralysate of liver.
    Kallai L; Kocić J
    Arzneimittelforschung; 1969 Jun; 19(6):1030-1. PubMed ID: 5820032
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical trial of a drug controlling liver fibrosis, lathyrogen (beta-mercaptoethylamine)].
    Ito K; Nakegawa J
    Saishin Igaku; 1969 Jan; 24(1):187-90. PubMed ID: 5777191
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.